Roche launches cobas® Liat® PCR System with four assays into CE-markets
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of the cobas® Liat® PCR System with four assays including first 20 minute real-time PCR nucleic acid test to detect Clostridium difficile (C. diff).
Read more
Roche receives CLIA waiver for cobas® Influenza A/B & RSV test for the cobas® Liat®
The first CLIA-waived, real-time PCR test that differentiates flu and RSV in 20 minutes is available now for use in physician offices and urgent care settings.
Read more
Roche Receives FDA CLIA Waiver for Flu A/B Test for use on its cobas® Liat® PCR System.
Roche today announced that the U.S. Food and Drug Administration (FDA) has granted CLIA (Clinical Laboratory Improvement Amendments) Waiver for the cobas® Influenza A/B test for use on the cobas® Liat® System.
Read more
Roche Receives FDA CLIA Waiver for the cobas® Liat® PCR System and cobas® Strep A Assay
cobas® Strep A, the first molecular PCR test to deliver laboratory-quality results in ~15 minutes, now available for use in physician offices and pharmacies
Read more
Roche Launches PCR Molecular Diagnostic System for Point-of-Care Environment
The cobas® Liat® System is the only FDA cleared molecular diagnostic platform to offer real- time PCR results in 20 minutes or less
Read more
Roche Receives FDA Clearance for Strep A Test on cobas® Liat® System (English)
The cobas® Strep A test is the first molecular point of care test to provide a result in 15 minutes for this common infection
Read more Roche Receives FDA Clearance for Strep A Test on cobas® Liat® System (French)
Le test cobas® Strep A est le premier test moléculaire réalisé au point de soins qui offre un résultat en 15 minutes pour cette infection courante
Read more Roche Receives FDA Clearance for Strep A Test on cobas® Liat® System (Spanish)
La prueba cobas® Strep A es la primera prueba molecular de análisis inmediato que proporciona un resultado en 15 minutos para esta infección tan común
Read more